Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00258115 · ClinicalTrials.gov registry record · Phase 2
The Study of Inflammation on Blood Glucose Levels in Obese People
A Phase 2 study, sponsored by Joslin Diabetes Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT00258115 is a Phase 2 study that has completed, run by Joslin Diabetes Center. The registered enrollment target is 20 participants.
The verdict
NCT00258115, a Phase 2 study, has completed, sponsored by Joslin Diabetes Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
Chronic subaccute inflammation may underlie the development of diabetes cardiovascular disease and other components of the metabolic syndrome. Rodent studies suggest diet induced obesity is associated with activation of the IKK/NF-kB pathway and this pathway can be inhibited by salicylates. This study seeks to determine the effect of salicylates in overweight persons.
Interventions
- DRUG salsalate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2003-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00258115
The ClinicalTrials.gov registry entry for NCT00258115 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which salsalate is the first listed.
NCT00258115 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00258115 about?
NCT00258115 is a clinical study titled "The Study of Inflammation on Blood Glucose Levels in Obese People". Chronic subaccute inflammation may underlie the development of diabetes cardiovascular disease and other components of the metabolic syndrome. Rodent studies suggest diet induced obesity is associated with activation of the IKK/NF-kB pathway and this pathway can be inhibited by salicylates. This stu...
What is the current status of trial NCT00258115?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2003-12.
What interventions are being tested in trial NCT00258115?
The interventions under investigation include: salsalate (DRUG).
Who is sponsoring clinical trial NCT00258115?
This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.